Sopharma AD-Sofia (XBUL:SFA) 5-Year Yield-on-Cost % : 23.96 (As of Jun. 04, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Sopharma AD-Sofia 5-Year Yield-on-Cost %?

Sopharma AD-Sofia's yield on cost for the quarter that ended in Dec. 2023 was 23.96.

The historical rank and industry rank for Sopharma AD-Sofia's 5-Year Yield-on-Cost % or its related term are showing as below:

XBUL:SFA' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.88 Med: 2.15 Max: 26.22
Current: 23.96

During the past 13 years, Sopharma AD-Sofia's highest Yield on Cost was 26.22. The lowest was 0.88. And the median was 2.15.

XBUL:SFA's 5-Year Yield-on-Cost % is ranked better than
95.31% of 64 companies
in the Medical Distribution industry
Industry Median: 3.71 vs XBUL:SFA: 23.96

Competitive Comparison of Sopharma AD-Sofia's 5-Year Yield-on-Cost %

For the Medical Distribution subindustry, Sopharma AD-Sofia's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sopharma AD-Sofia's 5-Year Yield-on-Cost % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's 5-Year Yield-on-Cost % falls into.

Sopharma AD-Sofia 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Sopharma AD-Sofia is calculated as

Yield-on-Cost

Dividend Yield %

Dividend Growth Rate)^5

Sopharma AD-Sofia (XBUL:SFA) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Sopharma AD-Sofia 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma AD-Sofia (XBUL:SFA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (XBUL:SFA) » Definitions » 5-Year Yield-on-Cost %

Comparable Companies

Traded in Other Exchanges

SPH:Poland

Address

5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756

Website

https://www.sopharmagroup.com

Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are organized based on the production of finished products which include Tablet dosage forms, Ampoule dosage forms, Medical products, Other forms, and Other revenue. Geographically company operates in Bulgaria and internationally.

Sopharma AD-Sofia (XBUL:SFA) Headlines

No Headlines